GB00BSG2DB72 20270610 382.9 (GG2DB7) ニュース

Steady_T " up front signals that BP takes DCVax-l seriously and believes in its future."
Are you saying that the big $$$$ up front were provided by BP???

Yeah, the key word was "Imagine"

But yeah you're definitely right. Only in the those not in the right mind, would say NWBO is their best investment. As of today, NWBO prove nothing to their investors.

I saw that earlier .... hopefully justice will be serve, but I'm not holding me breath!!!

Wow! You still can afford internet service?! 

I've always been disappointed when I expected something really new to be announced in presentations at an Institutional or investors conference. I'll agree that JPM may be positioning itself for something in the near future, but doubt it will be mentioned at the conference.

I'd be su

Retail isn't shorting this 🤣

MartyDg, ask yourself how could NWBO secure an agreement to get them 50 mil at this stage of the game?
It is an agreement for York to sell up to $50M of stock into the market. And if York cannot sell it at the price NWBO wants, then if does not happen.

The idea this is any sort

When the people that allow these pos to be released, no matter the reason, are held responsible for the actions of those they release, I'll bet their decisions will be rethought!!

Thanks RIO. Great information

Researchers significantly improve SCR catalytic performance for NOx reduction from hydrogen-fueled combustion engines
12 October 2024
A team of researchers from University of California Riverside, BASF, Virginia Tech and Brookhaven National Laboratory have mixed platinum (Pt) catalyst

Oh I thought they already inked the contract and they are just waiting for confirmation which is UK approval? Okay, whatever you said. Whatever you believe in. lol

A possible Parkinson's trial primary or secondary endpoint?

AI Overview
Yes, the brain shrinks with Parkinson's disease:
Brain regions affected
The parts of the brain that shrink include the temporal lobes, occipital lobes, frontal gyri, caudate tail, putamen, an

A groundbreaking development from the University of Alberta has introduced a new aluminum-nickel alloy, AlCrTiVNi5, poised to revolutionize hydrogen combustion engines. This alloy offers remarkable thermomechanical properties, making it ideal for enduring the extreme temperatures of hydrogen combust

As a fellow and proud knucklehead, here is a slightly different way of asking ChatGTP similar, but perhaps less leading questions.

Q1: Does the JMP healthcare conferences have 90 minutes presentations slots and If so, what are the criterion by which a company Is a assigned such longer

style="caret-color: rgb(27, 27, 27); color: rgba(27, 27, 27, 1); font-family: -apple-system-font; font-size: 18px; background-color: rgba(255, 255, 255, 1)"Good story.  The SEC really put Yorkville through the wringer but they came out on top after the damage was done.  This guy's comments could app

That doesn't answer the question of why they need to get 50 million from somewhere else instead of your favorite team, Merck. This suggests that Merck is not interested in lending them any cash, even after the approval. Why? Because they are not in talks, unlike your speculation.

So now recently, in context: It is being shown how even IHUB posters are validating the context of the appointment of a new corporation secretary, replacing the also elsewhere connected: Now former corporate secretary. Even the language of the "Cease and Desist" demand from a former contractor hig

Jan 20th can't come soon enough. Let's dispose of this garbage.

Indeed. Talk about flip flopping like a fish out of water....

It's going to copper land !!!

It's going to trips !!!

It's going to copper land !!! .....

Hilarious.

nwbo's latest funding is a routine PIPES deal. Not great. Not terrible. It's what Linda needs to keep the lights on.

It's close to risk free for Yorkville. They sell the stock in advance, then receive it from nwbo at a lower price. All trading, nothing long term, conveys no infor

BTW, 100 million is less than a third of what Merck just paid for merely the tech transfer (on a license) on a post mouse study me too bispecific antibody, and Merck is set to pay 2.7 billion for meeting milestones plus royalties.
Exactly and that is why the absence of any deal with any larg

Yes, you are right, rx. I specified a buyout. I would expect JPM to recommend afterwards if a partnership deal were announced at the conference. I think there is a very good chance they recommend even if Missling decides (as I believe he will) to wait on actually consummating a partnership (or mo

Perhaps but why not create an algos to "outpace" the spoofing algos or one to counter the offer? This all assuming they know the stock is being spoofed, as some here have alleged.